Study to Evaluate QLS-101 Compared to Timolol Maleate Eye Drops in Subjects With High Eye Pressure (Glaucoma or Ocular Hypertension).
Clinical trial NCT04830397 · COMPLETED
Trial details
- NCT number
- NCT04830397
- Sponsor
- Qlaris Bio, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-31
- Primary completion
- 2022-02-17
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.